AdaptHealth amends 8-K to disclose COO Daniel McFadden's compensation: base salary raised to $550K, plus RSU grant

AdaptHealth Corp.

Base salary increased from $410K to $550K retroactive to May 4, 2026.
Annual target bonus set at 100% of base salary, pro-rated for FY2026.
One-time RSU grant valued at $464,110 with time-based (50%, 3-yr) and TSR-based (50%, 0-200%) vesting.
Grant is under the Second Amended and Restated 2019 Stock Incentive Plan.
This amends prior filing to correct date and add compensation details not previously determined.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Daniel McFadden

Chief Operating Officer

AHCO · AdaptHealth Corp.

Effective: 2026-05-04
Filed: June 1, 2026, 9:02 PM ET

the appointment of Daniel McFadden as Chief Operating Officer of the Company, effective as of May 4, 2026

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel McFadden was appointed as Chief Operating Officer at AdaptHealth Corp..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

the appointment of Daniel McFadden as Chief Operating Officer of the Company, effective as of May 4, 2026

View on SEC.gov

AdaptHealth Corp. filing history →

Source: SEC EDGAR

accession 0001104659-26-069119

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.